Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)
The immune responses stimulated by the heterologous boost with bivalent mRNA vaccine in the NDV-HXP-S primed groups were high especially among the hybrid immune subgroup. Thai Clinical Trial Registry: WHO REGISTRY PLATFORM- TCTR20230809003.
Authors
- Yupa Sabmee
- Viravarn Luvira (ORCID: https://orcid.org/0000-0001-9270-3720)
- Christina S. Polyak (ORCID: https://orcid.org/0000-0002-9801-2012)
- Ponthip Wirachwong
- Laina D. Mercer (ORCID: https://orcid.org/0000-0002-2517-8900)
- Piengthong Narakorn
- Jorge Flores (ORCID: https://orcid.org/0000-0001-5069-1186)
- Anan Jongkaewwattana (ORCID: https://orcid.org/0000-0003-2354-9883)
- Sira Nanthapisal (ORCID: https://orcid.org/0000-0003-3196-4657)
- Saranath Lawpoolsri (ORCID: https://orcid.org/0000-0003-4841-7924)
- Punnee Pitisuttithum (ORCID: https://orcid.org/0000-0003-3215-2183)
- Somchaiya Surichan (ORCID: https://orcid.org/0000-0002-1058-5247)
- Sant Muangnoicharoen (ORCID: https://orcid.org/0000-0002-8236-8954)
- Chatnapa Duangdee
- Rama Raghunandan (ORCID: https://orcid.org/0000-0001-8254-0809)
- Weerapong Phumratanaprapin (ORCID: https://orcid.org/0000-0001-5896-1961)
Institutions
- Thammasat University (TH)
- Program for Appropriate Technology in Health (US)
- National Science and Technology Development Agency (TH)
- Mahidol University (TH)
- Government of Thailand (TH)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
- National Center for Genetic Engineering and Biotechnology (TH)
Publication Details
- Journal
- Vaccine
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127601
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00